{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:49:30Z","timestamp":1778615370242,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Reliable markers measuring disease progression in Huntington\u2019s disease (HD), before and after disease manifestation, may guide a therapy aimed at slowing or halting disease progression. Quantitative electroencephalography (qEEG) may provide a quantification method for possible (sub)cortical dysfunction occurring prior to or concomitant with motor or cognitive disturbances observed in HD. In this pilot study we construct an automatic classifier distinguishing healthy controls from HD gene carriers using qEEG and derive qEEG features that correlate with clinical markers known to change with disease progression in HD, with the aim of exploring biomarker potential. We included twenty-six HD gene carriers (49.7\u2009\u00b1\u20098.5 years) and 25 healthy controls (52.7\u2009\u00b1\u20098.7 years). EEG was recorded for three minutes with subjects at rest. An EEG index was created by applying statistical pattern recognition to a large set of EEG features, which was subsequently tested using 10-fold cross-validation. The index resulted in a continuous variable ranging from 0 to 1: a low value indicating a state close to normal and a high value pointing to HD. qEEG features that correlate specifically with commonly used clinical markers in HD research were derived. The classification index had a specificity of 83%, a sensitivity of 83% and an accuracy of 83%. The area under the curve of the receiver operator characteristic curve was 0.9. qEEG analysis on subsets of electrophysiological features resulted in two highly significant correlations with clinical scores. The results of this pilot study suggest that qEEG may serve as a biomarker in HD. The indices correlating with modalities changing with the progression of the disease may lead to tools based on qEEG that help monitor efficacy in intervention studies.<\/jats:p>","DOI":"10.1038\/s41598-018-34269-y","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T05:26:54Z","timestamp":1540445214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["EEG may serve as a biomarker in Huntington\u2019s disease using machine learning automatic classification"],"prefix":"10.1038","volume":"8","author":[{"given":"Omar F. F.","family":"Odish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristinn","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"van Someren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Gert","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"34269_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos, R. A. Huntington\u2019s disease: a clinical review. Orphanet J. Rare Dis. 5, 40 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"34269_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi, S. J. et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 8, 791\u2013801 (2009).","journal-title":"Lancet Neurol."},{"key":"34269_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.biopsych.2011.07.030","volume":"71","author":"EH Aylward","year":"2012","unstructured":"Aylward, E. H. et al. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol. Psychiatry. 71, 822\u2013828 (2012).","journal-title":"Biol. Psychiatry."},{"key":"34269_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/WNL.0b013e31826e9a5d","volume":"79","author":"TC Hadzi","year":"2012","unstructured":"Hadzi, T. C. et al. Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology. 79, 1708\u20131715 (2012).","journal-title":"Neurology."},{"key":"34269_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.58.5.695","volume":"58","author":"HD Rosas","year":"2002","unstructured":"Rosas, H. D. et al. Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease. Neurology. 58, 695\u2013701 (2002).","journal-title":"Neurology."},{"key":"34269_CR6","first-page":"213","volume":"75","author":"J Kassubek","year":"2004","unstructured":"Kassubek, J. et al. Topography of cerebral atrophy in early Huntington\u2019s disease: a voxel based morphometric MRI study. J. Neurol. Neurosurg. Psychiatry. 75, 213\u2013220 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"34269_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas, H. D. et al. Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain. 131, 1057\u20131068 (2008).","journal-title":"Brain."},{"key":"34269_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.brainresrev.2010.03.004","volume":"64","author":"L Nguyen","year":"2010","unstructured":"Nguyen, L., Bradshaw, J. L., Stout, J. C., Croft, R. J. & Georgiou-Karistianis, N. Electrophysiological measures as potential biomarkers in Huntington\u2019s disease: review and future directions. Brain Res. Rev. 64, 177\u2013194 (2010).","journal-title":"Brain Res. Rev."},{"key":"34269_CR9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S1388-2457(03)00074-9","volume":"114","author":"M de Tommaso","year":"2003","unstructured":"de Tommaso, M. et al. Detection of subclinical brain electrical activity changes in Huntington\u2019s disease using artificial neural networks. Clin. Neurophysiol. 114, 1237\u20131245 (2003).","journal-title":"Clin. Neurophysiol."},{"key":"34269_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney, J. B. et al. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann. Neurol. 41, 689\u2013692 (1997).","journal-title":"Ann. Neurol."},{"key":"34269_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 10, 31\u201342 (2011).","journal-title":"Lancet Neurol."},{"key":"34269_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1145\/1961189.1961199","volume":"2","author":"CC Chang","year":"2011","unstructured":"Chang, C. C. & Lin, C. J. LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol. 2, 27 (2011).","journal-title":"ACM Trans. Intell. Syst. Technol."},{"key":"34269_CR13","first-page":"297","volume":"19","author":"JW Cooley","year":"1965","unstructured":"Cooley, J. W. & John, W. An algorithm for the machine calculation of complex Fourier series. Tukey Journal: Math. Comp. 19, 297\u2013301 (1965).","journal-title":"Tukey Journal: Math. Comp."},{"key":"34269_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02291695","volume":"41","author":"H Wainer","year":"1976","unstructured":"Wainer, H. & Thissen, D. Three steps toward robust regression. Psychometrika. 41, 9\u201334 (1976).","journal-title":"Psychometrika."},{"key":"34269_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Machine learning. 20, 273\u2013297 (1995).","journal-title":"Machine learning."},{"key":"34269_CR16","unstructured":"Swets, J. A. Signal detection theory and ROC analysis in psychology and diagnostics: collected papers. Chapter 8, \u201cEnhancing and Evaluating Diagnostic Accuracy\u201d. Page 185. Lawrence Erlbaum Associates, Mahwah, NJ (1996)."},{"key":"34269_CR17","first-page":"1137","volume":"2","author":"R Kohavi","year":"1995","unstructured":"Kohavi, R. A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence. San Mateo, CA: Morgan Kaufmann. 2, 1137\u20131143 (1995).","journal-title":"San Mateo, CA: Morgan Kaufmann."},{"key":"34269_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/01.wnl.0000341768.28646.b6","volume":"72","author":"S Kl\u00f6ppel","year":"2009","unstructured":"Kl\u00f6ppel, S. et al. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurol. 72, 426\u2013431 (2009).","journal-title":"Neurol."},{"key":"34269_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuroimage.2010.04.273","volume":"56","author":"A Rizk-Jackson","year":"2011","unstructured":"Rizk-Jackson, A. et al. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington\u2019s disease using machine learning techniques. NeuroImage. 56, 788\u2013796 (2011).","journal-title":"NeuroImage."},{"key":"34269_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1073858405277450","volume":"11","author":"SW Hughes","year":"2005","unstructured":"Hughes, S. W. & Crunelli, V. Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist. 11, 357\u2013372 (2005).","journal-title":"Neuroscientist."},{"key":"34269_CR21","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1523\/JNEUROSCI.1486-08.2008","volume":"28","author":"B Draganski","year":"2008","unstructured":"Draganski, B. et al. Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia. J. Neurosci. 28, 7143\u20137152 (2008).","journal-title":"J. Neurosci."},{"key":"34269_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0028-3932(94)90001-9","volume":"32","author":"FW Bylsma","year":"1994","unstructured":"Bylsma, F. W. et al. EEG power spectra in Huntington\u2019s disease: clinical and neuropsychological correlates. Neuropsychologia. 32, 137\u2013150 (1994).","journal-title":"Neuropsychologia."},{"key":"34269_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s00415-010-5852-5","volume":"258","author":"A Painold","year":"2011","unstructured":"Painold, A. et al. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington\u2019s disease. J. Neurol. 258, 840\u2013854 (2011).","journal-title":"J. Neurol."},{"key":"34269_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jns.2014.06.035","volume":"344","author":"N Ponomareva","year":"2014","unstructured":"Ponomareva, N. et al. Alpha-theta border EEG abnormalities in preclinical Huntington\u2019s disease. J. Neurol. Sci. 344, 114\u2013120 (2014).","journal-title":"J. Neurol. Sci."},{"key":"34269_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1550059416632413","volume":"48","author":"C Piano","year":"2017","unstructured":"Piano, C. et al. Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature. Clin. EEG Neurosci. 48, 60\u201371 (2017).","journal-title":"Clin. EEG Neurosci."},{"key":"34269_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0197-4580(90)90057-7","volume":"11","author":"LJ Streletz","year":"1990","unstructured":"Streletz, L. J., Reyes, P. F., Zalewska, M., Katz, L. & Fariello, R. G. Computer analysis of EEG activity in dementia of the Alzheimer\u2019s type and Huntington\u2019s disease. Neurobiol. Aging. 11, 15\u201320 (1990).","journal-title":"Neurobiol. Aging."},{"key":"34269_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00702-010-0491-7","volume":"117","author":"A Painold","year":"2010","unstructured":"Painold, A. et al. Comparative EEG mapping studies in Huntington\u2019s disease patients and controls. J. Neural. Transm. 117, 1307\u20131318 (2010).","journal-title":"J. Neural. Transm."},{"key":"34269_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mds.21390","volume":"22","author":"K van der Hiele","year":"2007","unstructured":"van der Hiele, K. et al. Memory activation reveals abnormal EEG in preclinical Huntington\u2019s disease. Mov. Disord. 22, 690\u2013695 (2007).","journal-title":"Mov. Disord."},{"key":"34269_CR29","doi-asserted-by":"publisher","first-page":"RRN1192","DOI":"10.1371\/currents.RRN1192","volume":"2","author":"A Hunter","year":"2010","unstructured":"Hunter, A., Bordelon, Y., Cook, I. & Leuchter, A. QEEG Measures in Huntington\u2019s Disease: A Pilot Study. PLoS Curr. 2, RRN1192 (2010).","journal-title":"PLoS Curr."},{"key":"34269_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijpsycho.2005.03.016","volume":"57","author":"B Schack","year":"2005","unstructured":"Schack, B., Klimesch, W. & Sauseng, P. Phase synchronization between theta and upper alpha oscillations in a working memory task. Int. J. Psychophysiol. 57, 105\u2013114 (2005).","journal-title":"Int. J. Psychophysiol."},{"key":"34269_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.neuroimage.2009.01.001","volume":"45","author":"K Jann","year":"2009","unstructured":"Jann, K. et al. BOLD correlates of EEG alpha phase-locking and the fMRI default mode network. Neuroimage. 45, 903\u2013916 (2009).","journal-title":"Neuroimage."},{"key":"34269_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.tics.2012.10.007","volume":"16","author":"W Klimesch","year":"2012","unstructured":"Klimesch, W. Alpha-band oscillations, attention, and controlled access to stored information. Trends Cogn. Sci. 16, 606\u2013617 (2012).","journal-title":"Trends Cogn. Sci."},{"key":"34269_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/schbul\/sbn070","volume":"34","author":"G Gonzalez-Burgos","year":"2008","unstructured":"Gonzalez-Burgos, G. & Lewis, D. A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 34, 944\u2013961 (2008).","journal-title":"Schizophr. Bull."},{"key":"34269_CR34","first-page":"559","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J. P. et al. Neuropathological classification of Huntington\u2019s disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577 (1985).","journal-title":"Exp. Neurol."},{"key":"34269_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond, L. A. et al. Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 198, 252\u2013273 (2011).","journal-title":"Neuroscience."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34269-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34269-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34269-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:41:36Z","timestamp":1775252496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34269-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34269"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34269-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"1 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.J. is an employee of MentisCura ehf., which is a privately owned for-profit enterprise. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16090"}}